Stada Group
Xavi Lorenz has extensive experience in pharmaceutical sales, currently serving as the Pharmacy Sales Area Manager at STADA Group since January 2022. Prior to this role, Xavi worked as a Sales Representative at STADA from April 2015 to March 2022. Xavi's career in the pharmaceutical industry began at LABORATORIOS VIÑAS as a DELEGADO FARMACÉUTICO from June 2013 to November 2014, where responsibilities included product sales, client loyalty development, stock management, new client acquisitions, and merchandising.
This person is not in any teams
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.